White House-backed bill to help states track banned providers passes House

The Ensuring Removal of Terminated Providers from Medicaid and CHIP Act (HR 3716), which helps states identify healthcare providers who have been banned from Medicare, a Medicaid program, or the Children’s Health Insurance Program, has been unanimously approved by the U.S. House.

The legislation also included The Medicaid Directory of Caregivers Act (HR 3821), which requires states operating a fee-for-service or primary care case management program to provide a directory of physicians who served Medicaid patients in the prior year.

U.S. Representatives Chris Collins and Paul Tonko, who introduced HR 3821, both spoke on today’s news.

“Ensuring Medicaid beneficiaries can quickly and easily find out what doctors they can visit is a commonsense and simple fix,” Collins said in a prepared statement. “This legislation will increase health care access and efficiency for the most vulnerable, while reducing emergency room care. It’s a win-win. I want to thank Congressman Tonko for his steadfast efforts in helping to pass this vital reform through the House and look forward to this legislation being signed into law.”

“Ensuring Medicaid beneficiaries have the all the information they need when seeking care is a commonsense safeguard in our system,” Tonko said in the same statement. “This bill will make it easier for patients to know their options and find a doctor. I have enjoyed working with Congressman Collins on this legislation, and I thank him for his work to improve care for Medicaid patients.”

The White House showed its support of the bill with a Statement of Administration Policy released earlier this week.

“The Affordable Care Act requires that State Medicaid programs terminate participation of health care providers that have been terminated by Medicare or another State Medicaid program,” the statement read. “This legislation would improve States' ability to fulfill this requirement by codifying this requirement in CHIP, requiring providers participating in Medicaid and CHIP managed care to enroll with the State, and increasing required reporting, sharing of information, and standardization of documentation of reasons for termination.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.